For researchers weighing Swiss Chems alternatives on a risk-adjusted basis, this regulatory profile is relevant
Microdosing is an appealing approach for a number of reasons: Fewer Side Effects One of the biggest reasons why people quit taking GLP-1 medications is their side effects, which can include nausea, stomach pain, diarrhea, constipation, vomiting, and fatigue
Prioritizing protein prevents muscle loss, ensuring that weight lost comes primarily from fat stores
Dysesthesia This covers abnormal sensations that do not fit neatly into pain or sensitivity categories
By contrast, GLP-1RAs dosing over the long term may only slightly increase systolic blood pressure by 2 mmHg [104]
Many steroids convert to estrogen through the aromatase enzyme, producing water retention, potential gynecomastia, and a softer appearance that contradicts recomposition goals